Literature DB >> 26070527

Altered expression of P2Y2 and P2X7 purinergic receptors in the isolated rat heart mediates ischemia-reperfusion injury.

Miriam Granado1, Sara Amor1, Juan José Montoya2, Luis Monge1, Nuria Fernández1, Ángel Luis García-Villalón3.   

Abstract

The aim of this study is to analyze the expression of purinergic receptors in the heart after ischemia-reperfusion, and their possible role in ischemia-reperfusion injury. Rat hearts were perfused according to the Langendorff technique and subjected to 30 min ischemia followed by 15 min reperfusion. Ischemia-reperfusion reduced the gene expression and protein content of purinergic receptors of the P2Y2 subtype, and increased the gene expression and protein content of the P2X7 subtype. Treatment with the agonist of the P2Y2 subtype 2-thio-UTP and with the antagonist of the P2X7 subtype Brilliant Blue improved myocardial function parameters, reduced cell death and increased the myocardial expression of antiapoptotic markers after ischemia-reperfusion. These results suggest that the myocardial expression of the protective P2Y2 subtype of purinergic receptors is reduced, whereas that of the harmful subtype P2X7 subtype is increased during coronary ischemia-reperfusion. This may contribute to myocardial injury in this condition.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ischemia–reperfusion; Langendorff; P2Y2, P2X7; Purinergic receptors

Mesh:

Substances:

Year:  2015        PMID: 26070527     DOI: 10.1016/j.vph.2015.06.003

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  7 in total

Review 1.  Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.

Authors:  Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi
Journal:  Nat Rev Cardiol       Date:  2019-01       Impact factor: 32.419

Review 2.  Purinergic signaling in myocardial ischemia-reperfusion injury.

Authors:  Yi Zhuang; Mei-Ling Yu; Sheng-Feng Lu
Journal:  Purinergic Signal       Date:  2022-03-07       Impact factor: 3.765

3.  Aerobic Exercise Inhibited P2X7 Purinergic Receptors to Improve Cardiac Remodeling in Mice With Type 2 Diabetes.

Authors:  Ting Wang; Jianmin Li; Hui Li; Xin Zhong; Luya Wang; Shujue Zhao; Xuesheng Liu; Zhouqing Huang; Yonghua Wang
Journal:  Front Physiol       Date:  2022-05-31       Impact factor: 4.755

Review 4.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

Review 5.  Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2.

Authors:  Fernanda Dos Anjos; Júlia Leão Batista Simões; Charles Elias Assmann; Fabiano Barbosa Carvalho; Margarete Dulce Bagatini
Journal:  J Immunol Res       Date:  2020-12-01       Impact factor: 4.818

6.  Control of Directed Cell Migration after Tubular Cell Injury by Nucleotide Signaling.

Authors:  Sabrina Gessler; Clara Guthmann; Vera Schuler; Miriam Lilienkamp; Gerd Walz; Toma Antonov Yakulov
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208

7.  P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression.

Authors:  Camila Guerra Martinez; Daniel Zamith-Miranda; Marcia Gracindo da Silva; Karla Consort Ribeiro; Izaíra Trincani Brandão; Celio Lopes Silva; Bruno Lourenço Diaz; Maria Bellio; Pedro Muanis Persechini; Eleonora Kurtenbach
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.